{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:23:25Z","timestamp":1789017805862,"version":"build-2803163510"},"reference-count":0,"publisher":"Probiologists Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.46439\/stemcell.1.005","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T11:28:08Z","timestamp":1613561288000},"source":"Crossref","is-referenced-by-count":5,"title":["Lysyl oxidase inhibition in primary myelofibrosis: A renewed strategy"],"prefix":"10.46439","volume":"1","member":"25620","published-online":{"date-parts":[[2020,12,31]]},"container-title":["Archives of Stem Cell and Therapy"],"original-title":[],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T11:28:09Z","timestamp":1613561289000},"score":1,"resource":{"primary":{"URL":"https:\/\/probiologists.com\/Article\/Lysyl-oxidase-inhibition-in-primary-myelofibrosis:-A-renewed-strategy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12,31]]}},"URL":"https:\/\/doi.org\/10.46439\/stemcell.1.005","relation":{},"subject":[],"published":{"date-parts":[[2020,12,31]]}}}